217 related articles for article (PubMed ID: 1541342)
1. The possible mechanism of naphthalene cataract in rat and its prevention by an aldose reductase inhibitor (ALO1576).
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):63-72. PubMed ID: 1541342
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a naphthalene cataract model in vitro.
Xu GT; Zigler JS; Lou MF
Exp Eye Res; 1992 Jan; 54(1):73-81. PubMed ID: 1541343
[TBL] [Abstract][Full Text] [Related]
3. Prevention of naphthalene-1,2-dihydrodiol-induced lens protein modifications by structurally diverse aldose reductase inhibitors.
Sato S; Sugiyama K; Lee YS; Kador PF
Exp Eye Res; 1999 May; 68(5):601-8. PubMed ID: 10328974
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
Lou MF; Xu GT; Zigler S; York B
Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
[TBL] [Abstract][Full Text] [Related]
5. Effect of aldose reductase inhibitors on naphthalene cataract formation in the rat.
Tao RV; Takahashi Y; Kador PF
Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1630-7. PubMed ID: 1901836
[TBL] [Abstract][Full Text] [Related]
6. Naphthalene-induced cataract in the rat. II. Contrasting effects of two aldose reductase inhibitors on glutathione and glutathione redox enzymes.
Tao RV; Holleschau AM; Rathbun WB
Ophthalmic Res; 1991; 23(5):272-83. PubMed ID: 1784459
[TBL] [Abstract][Full Text] [Related]
7. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
8. alpha-Lipoic acid alters post-translational modifications and protects the chaperone activity of lens alpha-crystallin in naphthalene-induced cataract.
Chen Y; Yi L; Yan G; Fang Y; Jang Y; Wu X; Zhou X; Wei L
Curr Eye Res; 2010 Jul; 35(7):620-30. PubMed ID: 20597648
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acetaminophen- and naphthalene-induced cataract and glutathione loss by CySSME.
Rathbun WB; Holleschau AM; Cohen JF; Nagasawa HT
Invest Ophthalmol Vis Sci; 1996 Apr; 37(5):923-9. PubMed ID: 8603877
[TBL] [Abstract][Full Text] [Related]
10. Involvement of aldose reductase in naphthalene cataract.
Lee AY; Chung SS
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):193-7. PubMed ID: 9430562
[TBL] [Abstract][Full Text] [Related]
11. Aldose reductase the major protein associated with naphthalene dihydrodiol dehydrogenase activity in rat lens.
Sato S
Invest Ophthalmol Vis Sci; 1993 Oct; 34(11):3172-8. PubMed ID: 8407226
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
Unakar N; Tsui J; Johnson M
Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
[TBL] [Abstract][Full Text] [Related]
13. Glutathione synthesis and glutathione redox pathways in naphthalene cataract of the rat.
Rathbun WB; Holleschau AM; Murray DL; Buchanan A; Sawaguchi S; Tao RV
Curr Eye Res; 1990 Jan; 9(1):45-53. PubMed ID: 1968827
[TBL] [Abstract][Full Text] [Related]
14. Cataract development induced by repeated oral dosing with FK506 (tacrolimus) in adult rats.
Ishida H; Mitamura T; Takahashi Y; Hisatomi A; Fukuhara Y; Murato K; Ohara K
Toxicology; 1997 Dec; 123(3):167-75. PubMed ID: 9355935
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis by calpain is an underlying mechanism for formation of sugar cataract in rat lens.
Azuma M; Inoue E; Oka T; Shearer TR
Curr Eye Res; 1995 Jan; 14(1):27-34. PubMed ID: 7720403
[TBL] [Abstract][Full Text] [Related]
16. Effects of novel hydantoin derivatives with aldose reductase inhibiting activity on galactose-induced cataract in rats.
Kato K; Nakayama K; Ohta M; Murakami N; Murakami K; Mizota M; Miwa I; Okuda J
Jpn J Pharmacol; 1990 Dec; 54(4):355-64. PubMed ID: 2128352
[TBL] [Abstract][Full Text] [Related]
17. Determination of AL01576 concentration in rat lenses and plasma by bioassay for aldose reductase activity measurements.
Hockwin O; Müller P; Krolczyk J; McCue BA; Mayer PR
Ophthalmic Res; 1989; 21(4):285-91. PubMed ID: 2511536
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
Unakar NJ; Tsui JY
Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
[TBL] [Abstract][Full Text] [Related]
19. [Aldose reductase inhibitor--a new way for preventing diabetic lens changes?].
Ohrloff C; Hockwin O; Korte I; Wegener A
Klin Monbl Augenheilkd; 1986 Nov; 189(5):361-2. PubMed ID: 3100860
[TBL] [Abstract][Full Text] [Related]
20. Decreased chaperone activity of alpha-crystallins in naphthalene-induced cataract possibly results from C-terminal truncation.
Chen Y; Yi L; Yan GQ; Jang YX; Fang YW; Wu XH; Zhou XW; Wei LM
J Int Med Res; 2010; 38(3):1016-28. PubMed ID: 20819438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
